These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36216558)
1. Immunogenicity and protection against Glaesserella parasuis serotype 13 infection after vaccination with recombinant protein LolA in mice. Guo Z; Jia Y; Huang C; Zhou Y; Chen X; Yin R; Guo Y; Wang L; Yuan J; Wang J; Yan P; Yin R J Vet Med Sci; 2022 Nov; 84(11):1527-1535. PubMed ID: 36216558 [TBL] [Abstract][Full Text] [Related]
2. Application of mouse model for evaluation of recombinant LpxC and GmhA as novel antigenic vaccine candidates of Glaesserella parasuis serotype 13. Jia YC; Chen X; Zhou YY; Yan P; Guo Y; Yin RL; Yuan J; Wang LX; Wang XZ; Yin RH J Vet Med Sci; 2021 Oct; 83(10):1500-1508. PubMed ID: 34393140 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel Haemophilus parasuis serovar 5 vaccine candidates using an immunoproteomic approach. Li G; Xie F; Li J; Liu J; Li D; Zhang Y; Langford PR; Li Y; Liu S; Wang C J Proteomics; 2017 Jun; 163():111-117. PubMed ID: 28528009 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs. Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL; BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764 [TBL] [Abstract][Full Text] [Related]
5. Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5. Li M; Song S; Yang D; Li C; Li G Vaccine; 2015 Mar; 33(14):1695-701. PubMed ID: 25704800 [TBL] [Abstract][Full Text] [Related]
6. Pili Subunit PilA Contributes to the Cytoadhesion of An J; Cai J; Zhang B; Li Y Appl Environ Microbiol; 2023 Apr; 89(4):e0200222. PubMed ID: 36920203 [TBL] [Abstract][Full Text] [Related]
7. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis. Hau SJ; Eberle KC; Brockmeier SL Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA). Olvera A; Pina S; Pérez-Simó M; Aragón V; Segalés J; Bensaid A Vaccine; 2011 Mar; 29(15):2797-802. PubMed ID: 21320547 [TBL] [Abstract][Full Text] [Related]
9. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention. Li M; Li C; Song S; Kang H; Yang D; Li G Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines. Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701 [TBL] [Abstract][Full Text] [Related]
11. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice. Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951 [TBL] [Abstract][Full Text] [Related]
12. TurboID Screening of the OmpP2 Protein Reveals Host Proteins Involved in Recognition and Phagocytosis of Jiang C; Ma N; Cao H; Zeng W; Ren J; Hu Y; Zhou J; Zhang M; Li C; Lang Y; Li W; He Q Microbiol Spectr; 2022 Oct; 10(5):e0230722. PubMed ID: 36094311 [TBL] [Abstract][Full Text] [Related]
13. Analysis of efficacy obtained with a trivalent inactivated Zhao Z; Liu H; Xue Y; Chen K; Liu Z; Xue Q; Wang C Can J Vet Res; 2017 Jan; 81(1):22-27. PubMed ID: 28154458 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of glutathione-binding protein A of Haemophilus parasuis as a vaccine candidate in a mouse model. Zhang Y; Li G; Xie F; Liu S; Wang C J Vet Med Sci; 2017 Jan; 79(1):184-187. PubMed ID: 27840377 [TBL] [Abstract][Full Text] [Related]
15. Protective Efficacy of an Inactive Vaccine Based on the LY02 Isolate against Acute Haemophilus parasuis Infection in Piglets. Li XH; Zhao GZ; Qiu LX; Dai AL; Wu WW; Yang XY Biomed Res Int; 2015; 2015():649878. PubMed ID: 26688815 [TBL] [Abstract][Full Text] [Related]
16. Immunogenic characterization of vaccines based on Haemophilus parasuis Nagasaki strain, OmpP2, OmpP5 and OmpD15, in colostrum-deprived pigs experimentally challenged with the same strain. Álvarez-Estrada Á; Martínez-Martínez S; Martín CG; García-Iglesias MJ; Pérez-Martínez C; Yubero-Delgado S; Guizzo JA; Frandoloso R; Rodríguez-Ferri EF Res Vet Sci; 2018 Aug; 119():292-301. PubMed ID: 30081339 [TBL] [Abstract][Full Text] [Related]
18. HbpA from Glaesserella parasuis induces an inflammatory response in 3D4/21 cells by activating the MAPK and NF-κB signalling pathways and protects mice against G. parasuis when used as an immunogen. Yang Z; Zhang Y; Zhao Q; Du S; Huang X; Wu R; Yan Q; Han X; Wen Y; Cao SJ Vet Res; 2024 Jul; 55(1):93. PubMed ID: 39075605 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the recombinant HxuCBA proteins encoded by hxuCBA gene cluster of Haemophilus parasuis in mice. Wen Y; Yan X; Wen Y; Cao S; He L; Ding L; Zhang L; Zhou P; Huang X; Wu R; Wen X Gene; 2016 Oct; 591(2):478-83. PubMed ID: 27378742 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins. Fu S; Zhang M; Xu J; Ou J; Wang Y; Liu H; Liu J; Chen H; Bei W Vaccine; 2013 Jan; 31(2):347-53. PubMed ID: 23149270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]